David Westenberg
Stock Analyst at Piper Sandler
(1.17)
# 1822
Out of 5,333 analysts
186
Total ratings
47.37%
Success rate
4.22%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
LH Labcorp Hldgs | Maintains: Neutral | 260 280 | 245.77 | 13.93% | 4 | May 6, 2025 | |
NEO NeoGenomics | Maintains: Overweight | 18 12 | 8.03 | 49.44% | 9 | May 6, 2025 | |
GH Guardant Health | Maintains: Overweight | 50 60 | 41.7 | 43.88% | 9 | May 6, 2025 | |
FLGT Fulgent Genetics | Maintains: Neutral | 16 23 | 19.67 | 16.93% | 8 | May 6, 2025 | |
ADPT Adaptive Biotechnolo... | Maintains: Overweight | 11 13 | 9.03 | 43.96% | 12 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 180 200 | 176.99 | 13% | 7 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 7 5 | 5.95 | -15.97% | 12 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 3 2 | 1.11 | 48.65% | 8 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 16 12 | 11.96 | 0.33% | 9 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 70 55 | 61.33 | -10.32% | 3 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 200 205 | 151.44 | 35.37% | 14 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 9 8 | 2.92 | 173.97% | 9 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 200 205 | 159.31 | 28.68% | 11 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 75 70 | 51.64 | 35.55% | 10 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 3 2 | 1.11 | 80.18% | 7 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 185 190 | 75.71 | 150.96% | 15 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 435 510 | 491.88 | 3.68% | 10 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 4 3 | 2.87 | 4.53% | 7 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 1 1 | n/a | n/a | 5 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 170 165 | n/a | n/a | 9 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 30 | n/a | n/a | 2 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 34 44 | n/a | n/a | 2 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | n/a | n/a | n/a | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 2 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Nov 21, 2017 |